# SEG P0 Blocker Resolution Status Report

**Document ID:** `SEG_P0_BLOCKER_RESOLUTION_STATUS_REPORT`  
**Mode:** `CONTROLLED CONTENT GOVERNANCE EXECUTION`  
**Review pathway:** `OWNER_GOVERNED_MEDICAL_REVIEW_PATHWAY`  
**Targets:** Drug HTML, OSCE Atlas, and PreTest  
**Resolution timestamp:** `2026-08-22T15:06:50+00:00` — observed execution timestamp

## 1. Executive determination

This batch resolved documented P0 blockers only as evidence-inventory, requirement-definition, and review-preparation work. It did not resolve the underlying source-authority, provenance, rights, clinical, visual, accessibility, OCR, assessment-quality, or approval gates. No source content was changed and no source was approved.

The available evidence confirms that the three retained P0 artifacts can proceed through the next evidence-closure and owner-governed review preparation steps, but none qualifies for `READY_FOR_NORMALIZATION` or source approval.

```text
APPROVED_SOURCES = NONE
NORMALIZATION = BLOCKED_PENDING_APPROVED_SOURCE
SOURCE_REGISTRY_APPROVAL_STATES = UNCHANGED
```

## 2. Consolidated status

| Source | Documented blocker resolution | Remaining blocker state | Source readiness |
|---|---|---|---|
| Drug HTML | Metadata inventory, clinical-field register, drug-safety checklist, and required decision domains documented against the locked artifact | Canonical identity/version, provenance, rights, metadata closure, and attributable clinical/drug-safety decisions remain open | `BLOCKED_PENDING_EVIDENCE` |
| OSCE Atlas | 14-image package inventory, per-image review checklist, labeling requirements, accessibility requirements, and provenance/rights gap register documented | Authoritative identity/version, per-member lineage, rights, complete visual/clinical/accessibility review, and attributable decisions remain open | `BLOCKED_PENDING_EVIDENCE` |
| PreTest | OCR issue register, source-to-text reconciliation workflow, question-inventory requirements, and answer/explanation validation requirements documented | Authoritative source, OCR comparison, completeness/numbering, answer/explanation evidence, provenance, rights, and attributable medical/assessment decisions remain open | `BLOCKED_PENDING_EVIDENCE` |

`BLOCKED_PENDING_EVIDENCE` is a readiness and evidence state only. It does not modify Queue state, Source Registry state, or approval state.

## 3. Drug HTML

### 3.1 Resolved at the documentation level

The exact retained artifact remains locked as `LOCAL_INTAKE_ARTIFACT`, `/home/ubuntu/upload/deepseek_html_20260615_a3266b.html`, 25,918 bytes, 394 lines, SHA-256 `5367711d08df2393cf852815b1b9d0ad4dac8240ac061cd88c71a53884e938ac`. The available structural inventory remains recorded as 19 `summaryData` sections, 21 `quick` entries, 47 `drugList` entities, and 20 `trapsList` entries.

The required metadata fields, clinical-field inventory, drug-safety review checklist, and required decision domains are now explicitly documented. This resolves uncertainty about **what must be checked**, not whether the fields are clinically complete or safe.

### 3.2 Remaining blockers and evidence required

The canonical title/source, publisher or custodian, version/edition/date, original locator, extraction/transformation history, complete provenance, rights and display/redistribution scope, professional-track/taxonomy evidence, technical lineage review, and dated attributable Emergency Medicine and Pharmacology/Drug Safety decisions remain required. The absence of an observed pairwise interaction table remains an observation only and cannot be treated as evidence that interactions are absent.

### 3.3 Next allowed action

Preserve the HTML unchanged, assemble the source/version/provenance/rights packet, and complete separate owner-governed Emergency Medicine, Pharmacology/Drug Safety, metadata, technical, rights, provenance, and audit review streams. Each finding must use exact section/entity locators and an append-only disposition event.

## 4. OSCE Atlas

### 4.1 Resolved at the documentation level

The locked asset remains `ATLAS_ASSET_OSCE_VISUAL_001` with inner SHA-256 `ca5a7f5713bf5101daa839a546633366d7b5b876604bd3dbf7cea2972d59f66e` and outer SHA-256 `8182d243fc762e29efba5adeda4233042f5e337846b3fbe819fcd374ef948758`. The package-level inventory confirms 14 PNG members, station text, validation notes, and archive integrity.

The batch defined the per-image visual checklist, clinical-label requirements, accessibility requirements, and provenance/rights field gaps. It also records that the existing readability notes cover only `016_first_degree_heart_block.png` and `142_acute_cholecystitis.png`; they do not establish quality for the remaining 12 images.

### 4.2 Remaining blockers and evidence required

The authoritative atlas/title, creator or custodian, version/date, original locator, source-to-image/text lineage, per-image rights, complete station mapping, full 14-image visual review, clinical-label validation, educational-suitability disposition, alt-text/equivalent access, assistive-technology evidence, technical review, track/taxonomy evidence, and dated attributable review decisions remain required.

The artifact-level claim referring to `CopyofEmergency-Medicine-FULL.pdf` does not establish authoritative identity or rights. The PNG set must remain separate from the Clinical Images source family.

### 4.3 Next allowed action

Preserve the package and its members unchanged, reconcile the complete 14-member inventory against the immutable package, obtain the authoritative source/rights/lineage evidence, and execute separate owner-governed Emergency Medicine/OSCE, Visual, Accessibility, technical, rights, provenance, and audit reviews. Every member must have an explicit disposition tied to its filename, hash, and locator.

## 5. PreTest

### 5.1 Resolved at the documentation level

The locked representation remains `UPD811-007`, `pretestnew_Study_Guide_UTF8.txt`, 131,490 bytes, 1,349 logical lines, SHA-256 `b4ba84879b1247b9aaeb6172c6dffcb7dcc0860f8894e4651b2bc8a9fd669166`. Known OCR/extraction corruption is now recorded in a dedicated issue register, with no correction performed.

The required read-only source-to-text reconciliation workflow, question-inventory fields, numbering/completeness requirements, and answer/explanation validation requirements are documented. This resolves uncertainty about **how the evidence must be reconciled**, not the actual OCR, question, answer, or explanation gaps.

### 5.2 Remaining blockers and evidence required

The authoritative `pretestnew.pdf` or independently verifiable equivalent, canonical title/owner/version/date/locator, immutable source-to-text comparison, OCR discrepancy log, question count and numbering baseline, completeness reconciliation, answer-key inventory, explanation/rationale inventory, rights, provenance, track/taxonomy, and dated attributable Emergency Medicine and Assessment Quality decisions remain required.

The absence of an answer-key or explanation inventory is not a finding that the retained representation lacks answers or explanations. Their status remains unresolved until authoritative comparison and item-level review are completed.

### 5.3 Next allowed action

Preserve the recovered text unchanged, obtain or recover the authoritative representation, perform read-only comparison and OCR discrepancy classification, and then execute separate owner-governed Emergency Medicine, Assessment Quality, technical/OCR, rights, provenance, metadata, and audit reviews. No question, answer, explanation, numbering, OCR character, or clinical claim may be invented or silently corrected.

## 6. Audit-trail update

The append-only audit register records the following blocker-resolution start events:

| Event ID | Source | Recorded action | Evidence basis | Limitation |
|---|---|---|---|---|
| `P0-AUD-015` | Drug HTML | Metadata inventory, clinical-field register, drug-safety checklist, and required decisions documented | Locked HTML artifact and prior closure assessment | Underlying clinical, safety, source, provenance, rights, metadata, and approval gates remain open |
| `P0-AUD-016` | OSCE Atlas | 14-image inventory, image checklist, labels, accessibility requirements, and provenance/rights gaps documented | Locked package, hashes, and prior closure assessment | Complete member-level visual, clinical, accessibility, source, lineage, rights, and approval gates remain open |
| `P0-AUD-017` | PreTest | OCR issue register, reconciliation requirements, question inventory, and answer/explanation validation requirements documented | Locked `UPD811-007` representation and prior closure assessment | Authoritative source, OCR comparison, completeness, answer/explanation, rights, provenance, medical, assessment, and approval gates remain open |

The events use the observed timestamp `2026-08-22T15:06:50+00:00`. They record governance-document execution only; they do not record clinical review completion or source approval.[5]

## 7. Global blockers and next allowed action

The batch has not closed any source-level gate. The remaining cross-source blockers are canonical identity/version, provenance and lineage, rights and permitted-use scope, professional-track/taxonomy evidence, attributable role-appropriate reviews, source-specific quality decisions, and explicit source-level approval.

The next allowed action is evidence closure and execution of the separate owner-governed review streams against the exact immutable artifacts. Any future correction, OCR repair, relabeling, transformation, or derivative must receive separate authorization, a new version/hash, a change record, and audit linkage.

## 8. Non-actions and controls

| Control/action | Result |
|---|---|
| Source approval | `NO` |
| `READY_FOR_NORMALIZATION` set | `NO` |
| Source content modified | `NO` |
| Content Records created | `NO` |
| Zod/Prisma/SQL/schema created | `NO` |
| Normalization performed | `NO` |
| Import/activation/publication | `NO` |
| Database/application changed | `NO` |
| Source Registry approval state changed | `NO` |
| `APPROVED_SOURCES` | `NONE` |
| `NORMALIZATION` | `BLOCKED_PENDING_APPROVED_SOURCE` |

## 9. Final status

`SEG_P0_BLOCKER_RESOLUTION_BATCH_COMPLETE`

This status confirms completion of the controlled blocker-resolution documentation batch and its audit-start events. It does not mean that any blocker was clinically resolved, that any source passed review, or that any source was approved or made ready for normalization.

## References

[1]: file:///home/ubuntu/seg-internship-output/SEG_DRUG_HTML_BLOCKER_RESOLUTION_REPORT.md "SEG Drug HTML Blocker Resolution Report"

[2]: file:///home/ubuntu/seg-internship-output/SEG_OSCE_ATLAS_BLOCKER_RESOLUTION_REPORT.md "SEG OSCE Atlas Blocker Resolution Report"

[3]: file:///home/ubuntu/seg-internship-output/SEG_PRETEST_BLOCKER_RESOLUTION_REPORT.md "SEG PreTest Blocker Resolution Report"

[4]: file:///home/ubuntu/seg-internship-output/SEG_OWNER_REVIEW_CLOSURE_ASSESSMENT_REPORT.md "SEG Owner Review Closure Assessment Report"

[5]: file:///home/ubuntu/seg-internship-output/SEG_P0_AUDIT_TRAIL_REGISTER.md "SEG P0 Audit Trail Register"

**Document status:** `P0_BLOCKER_RESOLUTION_DOCUMENTED_ALL_SOURCES_REMAIN_BLOCKED`
